Media

Filter by Category

All Blogs Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

June 12, 2020-June 18, 2020

The Rare Disease Clinical Outcome Assessment Consortium: Aiming to Fulfill Unmet Drug Development Endpoint Measurement Needs

Presented at the DIA Virtual Global Annual Meeting, held June 12 – 18, 2020.

An online case reporting platform has been optimized for COVID-19 and will be the springboard for a new public-private drug

September 6, 2020

This new webinar from the Center for Drug Evaluation (CDER), Division of Drug Information (DDI) is now available at:

May 6, 2020

May 14, 2020

TUCSON, Ariz., and OLDWICK, N.J. May 13, 2020 — The Critical Path Institute (C-Path) and Provention Bio, Inc. (Nas

TUCSON, Ariz., April 30, 2020 — Tucson-based Critical Path Institute (C-Path) today announced the appointment of two new

Recommendations provided for sponsors and eCOA providers to facilitate the continued collection of PRO data in clinical trials. &n

June 5, 2020

Join C-Path, the National Organization for Rare Disorders and the FDA for a free 1-hour webinar on the Rare Disease Cures Accelera

TUCSON, Ariz., April 28, 2020 — The Critical Path Institute (C-Path) today announced that its Type 1 Diabetes (T1D